Insider filings this week reveal a sharp split between sellers cashing out near highs and one bold CEO doubling down.
NVDA director Mark Stevens filed over $385 million in sales across June. He sold shares in three separate tranches at prices between $210 and $222. The filings covered trades from June 2 through June 18, reported to regulators within days of each transaction.
ASTS founder and CEO Abel Avellan filed a $146.7 million sale on June 23. He sold 2.5 million shares at $58.68 each. The company's CFO also filed a separate sale of $4.3 million earlier in the month.
The WMT Walton Family Holdings Trust filed two large sell blocks. The first, worth $467 million, was reported June 18. A second $184 million sale was reported June 4. Both are routine trust-level disposals, but the scale stands out.
The most striking contrarian move came from SMMT. Chairman and CEO Robert Duggan filed a $50 million purchase at $13.12 per share on June 12. SMMT's President and CFO also filed smaller purchases on June 4. Three insiders buying the same stock in the same week signals clear internal confidence in the biotech's pipeline.
This is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
